OptimizeRx Corp - Common Stock (OPRX)

CUSIP: 68401U204

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock
Shares outstanding
18,580,860
Total 13F shares
11,369,292
Share change
-1,031,348
Total reported value
$55,254,730
Put/Call ratio
195%
Price per share
$4.86
Number of holders
86
Value change
-$15,713,691
Number of buys
47
Number of sells
36

Quarterly Holders Quick Answers

What is CUSIP 68401U204?
CUSIP 68401U204 identifies OPRX - OptimizeRx Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OptimizeRx Corp - Common Stock (OPRX) as of Q4 2024

As of 31 Dec 2024, OptimizeRx Corp - Common Stock (OPRX) was held by 86 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 11,369,292 shares. The largest 10 holders included Whetstone Capital Advisors, LLC, BlackRock, Inc., ROYCE & ASSOCIATES LP, VANGUARD GROUP INC, BLAIR WILLIAM & CO/IL, KENNEDY CAPITAL MANAGEMENT LLC, RICE HALL JAMES & ASSOCIATES, LLC, DIMENSIONAL FUND ADVISORS LP, GEODE CAPITAL MANAGEMENT, LLC, and STATE STREET CORP. This page lists 86 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.